Gliadel Wafer
Product Images NDC 24338-050

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gliadel (NDC 24338-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Gliadel 01)

Figure 1 (Gliadel 01)
FDA Label Image

Figure 2 (Gliadel 02)

Figure 2 (Gliadel 02)
FDA Label Image

Figure 3 (Gliadel 03)

Figure 3 (Gliadel 03)
FDA Label Image

Figure 4 (Gliadel 04)

Figure 4 (Gliadel 04)
FDA Label Image

Figure 5 (Gliadel 05)

Figure 5 (Gliadel 05)
FDA Label Image

Chemical Structure (Gliadel 06)

Chemical Structure (Gliadel 06)
FDA Label Image

Chemical Structure (Gliadel 07)

Chemical Structure (Gliadel 07)
FDA Label Image

Figure 6 (Gliadel 08)

Figure 6 (Gliadel 08)
The text appears to be a graph showing the percentage of survival for the GLIADEL Wafer and placebo over time (months) from implant surgery. The LogRank test was used with a significance level of p<0.05. No further information is available.*
FDA Label Image

Figure 7 (Gliadel 09)

Figure 7 (Gliadel 09)
FDA Label Image

Figure 8 (Gliadel 10)

Figure 8 (Gliadel 10)
This is a mathematical formula that calculates the survival rate as a percentage. It is not clear what specific context or variables are being used in this formula.*
FDA Label Image

Principal Display Panel (8 Wafer Box)

Principal Display Panel (8 Wafer Box)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.